Genome Editing Market Report 2024: CRISPR/Cas9 are the Most
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Genome Editing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The
The methylotrophic yeast Pichia pastoris has emerged as a popular host system for recombinant protein production. With its ability to grow to high cell
A team of researchers at the Carl Gustav Carus Faculty of Medicine, TUD Dresden University of Technology, led by Prof. Frank Buchholz, has achieved a major breakthrough in genome editing technology.
Most approved gene therapies today, including those involving CRISPR-Cas9, work their magic on cells removed from the body, after which the edited cells are returned to the patient.
This study is led by Prof. Xianqun Fan (Department of Ophthalmology, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital).